| Valsartan for prevention of recurrent atrial fibrillation GISSI-AF Investigators New England Journal of Medicine 360 (16), 1606-1617, 2009 | 603 | 2009 |
| Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor–related apoptosis-inducing ligand delivery for cancer therapy G Grisendi, R Bussolari, L Cafarelli, I Petak, V Rasini, E Veronesi, ... Cancer research 70 (9), 3718-3729, 2010 | 310 | 2010 |
| " In vitro" and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal … G Astori, F Vignati, S Bardelli, M Tubio, M Gola, V Albertini, F Bambi, ... Journal of Translational Medicine 5, 1-10, 2007 | 266 | 2007 |
| Tumor microenvironment: bone marrow-mesenchymal stem cells as key players P Barcellos-de-Souza, V Gori, F Bambi, P Chiarugi Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1836 (2), 321-335, 2013 | 226 | 2013 |
| Mesenchymal stem cells are recruited and activated into carcinoma-associated fibroblasts by prostate cancer microenvironment-derived TGF-β1 P Barcellos-de-Souza, G Comito, C Pons-Segura, ML Taddei, V Gori, ... Stem cells 34 (10), 2536-2547, 2016 | 199 | 2016 |
| Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future G Astori, E Amati, F Bambi, M Bernardi, K Chieregato, R Schäfer, S Sella, ... Stem cell research & therapy 7, 1-8, 2016 | 196 | 2016 |
| Genome-wide association study on differentiated thyroid cancer A Köhler, B Chen, F Gemignani, R Elisei, C Romei, G Figlioli, M Cipollini, ... The Journal of Clinical Endocrinology & Metabolism 98 (10), E1674-E1681, 2013 | 126 | 2013 |
| Norepinephrine promotes tumor microenvironment reactivity through β3-adrenoreceptors during melanoma progression M Calvani, F Pelon, G Comito, ML Taddei, S Moretti, S Innocenti, ... Oncotarget 6 (7), 4615, 2015 | 112 | 2015 |
| GMP-manufactured density gradient media for optimized mesenchymal stromal/stem cell isolation and expansion G Grisendi, C Annerén, L Cafarelli, R Sternieri, E Veronesi, GL Cervo, ... Cytotherapy 12 (4), 466-477, 2010 | 107 | 2010 |
| Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors G Golinelli, G Grisendi, M Prapa, M Bestagno, C Spano, F Rossignoli, ... Cancer gene therapy 27 (7), 558-570, 2020 | 90 | 2020 |
| Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience V Becherucci, L Piccini, S Casamassima, S Bisin, V Gori, F Gentile, ... Stem cell research & therapy 9, 1-10, 2018 | 80 | 2018 |
| ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium C Rizzato, D Campa, R Pezzilli, P Soucek, W Greenhalf, G Capurso, ... Oncology reports 29 (4), 1637-1644, 2013 | 76 | 2013 |
| Bone marrow‐derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition L Pietrovito, A Leo, V Gori, M Lulli, M Parri, V Becherucci, L Piccini, ... Molecular oncology 12 (5), 659-676, 2018 | 72 | 2018 |
| Extremely low-frequency electromagnetic fields do not affect DNA damage and gene expression profiles of yeast and human lymphocytes C Luceri, CD Filippo, L Giovannelli, M Blangiardo, D Cavalieri, F Aglietti, ... Radiation Research 164 (3), 277-285, 2005 | 70 | 2005 |
| Mesenchymal progenitors aging highlights a miR-196 switch targeting HOXB7 as master regulator of proliferation and osteogenesis O Candini, C Spano, A Murgia, G Grisendi, E Veronesi, MS Piccinno, ... Stem Cells 33 (3), 939-950, 2015 | 69 | 2015 |
| TERT gene harbors multiple variants associated with pancreatic cancer susceptibility D Campa, C Rizzato, R Stolzenberg‐Solomon, P Pacetti, P Vodicka, ... International journal of cancer 137 (9), 2175-2183, 2015 | 67 | 2015 |
| Novel genome-wide association study–based candidate loci for differentiated thyroid cancer risk G Figlioli, A Köhler, B Chen, R Elisei, C Romei, M Cipollini, A Cristaudo, ... The Journal of Clinical Endocrinology & Metabolism 99 (10), E2084-E2092, 2014 | 56 | 2014 |
| Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium D Campa, C Rizzato, G Capurso, N Giese, N Funel, W Greenhalf, ... Digestive and liver disease 45 (2), 95-99, 2013 | 55 | 2013 |
| Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk D Campa, M Pastore, M Gentiluomo, R Talar-Wojnarowska, J Kupcinskas, ... Oncotarget 7 (35), 57011, 2016 | 49 | 2016 |
| Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study D Campa, M Matarazzi, W Greenhalf, M Bijlsma, KU Saum, C Pasquali, ... International journal of cancer 144 (6), 1275-1283, 2019 | 48 | 2019 |
STEFANO LANDIDipartimento di Biologia在 unipi.it 的电子邮件经过验证
